COVID-19 treatment and drug trials, including the combination of hydroxychloroquine and azithromycin, are top of mind across the nation and around the world. As this particular “drug cocktail” poses a deadly risk for patients with underlying, often unknown, heart conditions such as Long QT syndrome, it is critical that the medical community comes together to ensure necessary steps are taken to safely administer trial drug combinations.

Read more